| 1 | 26975630 | NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway. | Cancer Lett | 2016 Jun 28 |
1 |
| 2 | 28784305 | Dexmedetomidine (DEX) protects against hepatic ischemia/reperfusion (I/R) injury by suppressing inflammation and oxidative stress in NLRC5 deficient mice. | Biochem Biophys Res Commun | 2017 Nov 18 |
5 |
| 3 | 29070585 | NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation. | FASEB J | 2018 Feb |
2 |
| 4 | 29692724 | The Long Non-coding RNA MEG3/miR-let-7c-5p Axis Regulates Ethanol-Induced Hepatic Steatosis and Apoptosis by Targeting NLRC5. | Front Pharmacol | 2018 |
4 |
| 5 | 29907459 | NLRC5 deficiency protects against acute kidney injury in mice by mediating carcinoembryonic antigen-related cell adhesion molecule 1 signaling. | Kidney Int | 2018 Sep |
2 |
| 6 | 31253783 | NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ. | Nat Commun | 2019 Jun 28 |
4 |
| 7 | 31434695 | The deficiency of miR-214-3p exacerbates cardiac fibrosis via miR-214-3p/NLRC5 axis. | Clin Sci (Lond) | 2019 Sep 13 |
1 |
| 8 | 32273344 | The USP14-NLRC5 pathway inhibits titanium particle-induced osteolysis in mice by suppressing NF-κB and PI3K/AKT activities. | J Biol Chem | 2020 May 15 |
3 |
| 9 | 32539925 | MiR-520c-3p alleviates LPS-induced A549 cell and mice lung injury via targeting NLRC5. | Pharmazie | 2020 Jun 1 |
2 |